These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36118951)

  • 1. Current material engineering strategies to prevent catheter encrustation in urinary tracts.
    Yao Q; Wu C; Yu X; Chen X; Pan G; Chen B
    Mater Today Bio; 2022 Dec; 16():100413. PubMed ID: 36118951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model to quantify encrustation on ureteric stents, urethral catheters and polymers intended for urological use.
    Choong SK; Wood S; Whitfield HN
    BJU Int; 2000 Sep; 86(4):414-21. PubMed ID: 10971264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An antimicrobial impregnated urinary catheter that reduces mineral encrustation and prevents colonisation by multi-drug resistant organisms for up to 12 weeks.
    Belfield K; Chen X; Smith EF; Ashraf W; Bayston R
    Acta Biomater; 2019 May; 90():157-168. PubMed ID: 30914257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mussel-Inspired Clickable Antibacterial Peptide Coating on Ureteral Stents for Encrustation Prevention.
    Yao Q; Zhang J; Pan G; Chen B
    ACS Appl Mater Interfaces; 2022 Aug; 14(32):36473-36486. PubMed ID: 35917447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bio-inspired antibacterial coatings on urinary stents for encrustation prevention.
    Yao Q; Chen B; Bai J; He W; Chen X; Geng D; Pan G
    J Mater Chem B; 2022 Apr; 10(14):2584-2596. PubMed ID: 34984428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial and anti-encrustation biodegradable polymer coating for urinary catheter.
    Dayyoub E; Frant M; Pinnapireddy SR; Liefeith K; Bakowsky U
    Int J Pharm; 2017 Oct; 531(1):205-214. PubMed ID: 28830785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro antibacterial and anti-encrustation performance of silver-polytetrafluoroethylene nanocomposite coated urinary catheters.
    Wang L; Zhang S; Keatch R; Corner G; Nabi G; Murdoch S; Davidson F; Zhao Q
    J Hosp Infect; 2019 Sep; 103(1):55-63. PubMed ID: 30802524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifouling coating with controllable and sustained silver release for long-term inhibition of infection and encrustation in urinary catheters.
    Wang R; Neoh KG; Kang ET; Tambyah PA; Chiong E
    J Biomed Mater Res B Appl Biomater; 2015 Apr; 103(3):519-28. PubMed ID: 24922113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo study of antibacterial and anti-encrustation coating on ureteric stents.
    Zhao Y; Chen G; Yushanjiang S; Zhao M; Yang H; Lu R; Qu R; Dai Y; Yang L
    BJU Int; 2024 Jul; 134(1):72-80. PubMed ID: 38459675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to Improve Patient Outcomes and QOL: Current Complications of the Design and Placements of Ureteric Stents.
    Ramachandra M; Mosayyebi A; Carugo D; Somani BK
    Res Rep Urol; 2020; 12():303-314. PubMed ID: 32802807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Restriction of in vivo infection by antifouling coating on urinary catheter with controllable and sustained silver release: a proof of concept study.
    Mandakhalikar KD; Wang R; Rahmat JN; Chiong E; Neoh KG; Tambyah PA
    BMC Infect Dis; 2018 Aug; 18(1):370. PubMed ID: 30081836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for the control of catheter encrustation.
    Stickler DJ; Evans A; Morris N; Hughes G
    Int J Antimicrob Agents; 2002 Jun; 19(6):499-506. PubMed ID: 12135840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ureteral Stent Encrustation: Epidemiology, Pathophysiology, Management and Current Technology.
    Tomer N; Garden E; Small A; Palese M
    J Urol; 2021 Jan; 205(1):68-77. PubMed ID: 32856981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high throughput, minimally invasive, ultrasound guided model for the study of catheter associated urinary tract infections and device encrustation in mice.
    Janssen C; Lo J; Jäger W; Moskalev I; Law A; Chew BH; Lange D
    J Urol; 2014 Dec; 192(6):1856-63. PubMed ID: 24866596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encrustation and strength retention properties of the self-expandable, biodegradable, self-reinforced L-lactide-glycolic acid co-polymer 80:20 spiral urethral stent in vitro.
    Laaksovirta S; Välimaa T; Isotalo T; Törmälä P; Talja M; Tammela TL
    J Urol; 2003 Aug; 170(2 Pt 1):468-71. PubMed ID: 12853801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encrusted urinary stents: evaluation and endourologic management.
    Vanderbrink BA; Rastinehad AR; Ost MC; Smith AD
    J Endourol; 2008 May; 22(5):905-12. PubMed ID: 18643720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into the prevention of ureteral stents encrustation.
    Guo H; Yuan JB
    Open Med (Wars); 2023; 18(1):20230854. PubMed ID: 38075034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Latest advancements in ureteral stent technology.
    De Grazia A; Somani BK; Soria F; Carugo D; Mosayyebi A
    Transl Androl Urol; 2019 Sep; 8(Suppl 4):S436-S441. PubMed ID: 31656749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of PEO/PTMO multiblock copolymer/segmented polyurethane blends as coating materials for urinary catheters: in vitro bacterial adhesion and encrustation behavior.
    Park JH; Cho YW; Kwon IC; Jeong SY; Bae YH
    Biomaterials; 2002 Oct; 23(19):3991-4000. PubMed ID: 12162332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center, double-blind, randomized, placebo-controlled pilot study of Canoxidin® for prevention of catheter encrustation in patients with indwelling catheters.
    Borau A; Amaya E; Delía P; Alves MJ; Morcillo M; Ustrell A; Opisso E
    Actas Urol Esp (Engl Ed); 2024 Jul; ():. PubMed ID: 38960062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.